Skip to Content

This $40,000 Robotic Exoskeleton Lets the Paralyzed Walk

Still pricier than motorized wheelchairs, SuitX’s Phoenix exoskeleton weighs just 27 pounds and is custom-fit to the user’s body.
February 1, 2016

Paralyzed from the waist down after a BMX accident, Steven Sanchez rolled into SuitX’s Berkeley, California, office in a wheelchair. A half-hour later he was standing and walking thanks to the Phoenix—a robotic exoskeleton now available for around $40,000.

The suit returns movement to wearers’ hips and knees with small motors attached to standard orthotics. Wearers can control the movement of each leg and walk at up to 1.1 miles per hour by pushing buttons integrated into a pair of crutches.

At 27 pounds, the Phoenix is among the lightest and cheapest medical exoskeletons. It also has unique abilities; the suit is modular and adjustable so it can adapt to, say, a relatively tall person who just needs mobility assistance for one knee.

A battery pack worn as a backpack powers the exoskeleton for up to eight hours.

A battery pack worn as a backpack powers the exoskeleton for up to eight hours. An app can be used to track the patient’s walking data. SuitX has mainly worked with patients with spinal cord injuries, who can use the Phoenix to walk again.

“We can’t really fix their disease. We can’t fix their injury. But what it would do is postpone the secondary injuries due to sitting,” says SuitX founder and CEO Homayoon Kazerooni. “It gives a better quality of life.”

Paralyzed from the waist down after a BMX accident, Steven Sanchez rolled into SuitX’s Berkeley, California, office in a wheelchair. A half-hour later he was standing and walking thanks to the Phoenix—a robotic exoskeleton now available for around $40,000.

The technology behind SuitX’s industrial and medical exoskeleton originated at the Robotics and Human Engineering Laboratory at the University of California, Berkeley, which Kazerooni leads. He said his major goal is to build a version of the exoskeleton for children. Children with neurological disorders sometimes need intensive walking training or can risk losing their mobility.

The device could also have therapeutic benefits for people who have experienced a stroke or other motor injury, but more research needs to be conducted.

SuitX is just one of the companies hoping to boost interest in exoskeleton research. Competing suits like the ReWalk, which costs $70,000 and weighs about 50 pounds, are striving to reduce costs while improving functionality. If exoskeleton makers can drive suit costs down to a few thousand dollars, they could start competing with motorized wheelchairs (see “The Exoskeletons Are Coming”).

Volker Bartenbach, an exoskeleton researcher at ETH Zurich, says a combination of performance, price, and clinically proven benefits will give rise to the first widely adopted exoskeleton.

“Speed, operating time, mobility, and usability have to be good enough so that those systems are perceived as better by the user than the alternatives,” Bartenbach says. “If you need 10 minutes to walk to the bakery 300 feet away in your exoskeleton that takes five minutes to put on, you will probably use the wheelchair instead.”

Sanchez travels the world with SuitX demoing the Phoenix exoskeleton. A picture above the entrance to the company’s office features Sanchez, standing upright, smiling in front of the Colosseum in Rome. But during an evening in late January, he was just interested in the chance to extend and stretch his body.

Standing is an essential exercise for Sanchez if he wants to avoid sores and other injuries. Before Phoenix, he was training to kill the nerves in his hands so he could spend more time supporting his body’s weight while walking with crutches.

The custom carbon-fiber orthotics that hold the Phoenix to his body just look like braces. The device’s movements make no noise. The most noticeable part of the getup is the crutches. The Phoenix still needs too much maintenance for Sanchez to take one home, but he’s hopeful that SuitX will give him a unit someday.

“If I had this it would change a lot of things,” Sanchez says. “It’s a necessity at this point.”

Keep Reading

Most Popular

Scientists are finding signals of long covid in blood. They could lead to new treatments.

Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.

Large language models can do jaw-dropping things. But nobody knows exactly why.

And that's a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.

OpenAI teases an amazing new generative video model called Sora

The firm is sharing Sora with a small group of safety testers but the rest of us will have to wait to learn more.

Google’s Gemini is now in everything. Here’s how you can try it out.

Gmail, Docs, and more will now come with Gemini baked in. But Europeans will have to wait before they can download the app.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.